During your opponent's next turn, prevent all damage done to this Pokémon by attacks from Pokémon-GX and Pokémon-EX.
This attack's damage isn't affected by any effects on your opponent's Active Pokémon.
Your opponent's Active Pokémon is now Asleep. Heal all damage from all of your Pokémon. (You can't use more than 1 GX attack in a game.)
Dragon Majesty was released in 2018. Dragon Majesty is grouped under the Sun & Moon era.
With 80 listed cards, this is a compact set by modern TCG standards. As of 2026, the set is 8 years old and now falls into an established back-catalog period.
In the Dragon Majesty checklist, Altaria-GX occupies position #72 as a Rare Rainbow card.
Altaria-GX appears in Dragon Majesty, released in 2018. Its card type is Pokémon.
The rarity label is Rare Rainbow. Printed HP is 200.
Energy typing is Dragon. This gives collectors a clear identity footprint for the print.
Altaria-GX evolves from Swablu. Card rules text: Pokémon-GX rule: When your Pokémon-GX is Knocked Out, your opponent takes 2 Prize cards.
Current market pricing for Altaria-GX (Dragon Majesty) sits near $37.41. The 7-day delta remains near neutral at 0.0%.
Current pricing is broadly aligned with its 30-day average ($37.11). The 90-day window shows a floor near $36.09 and a peak around $37.41 (4% total spread), which maps to low-volatility movement.
Rarity classification for this copy is Rare Rainbow.
Altaria-GX sits within a broader pool of Altaria-GX variants that can be compared by set, rarity, and price. The current sample spans 3 comparable cards from 2 sets.
Observed alternatives run from $3.40 to $21.28 (526% spread). The current card sits +246% versus the sampled alternative average of $10.82.
Notable alternatives include Altaria-GX #SV77 (Hidden Fates Shiny Vault) at $21.28, Altaria-GX #68 (Dragon Majesty) at $7.79, and Altaria-GX #41 (Dragon Majesty) at $3.40.
Market structure summary: Weekly drift is minimal (0.0%), indicating a relatively balanced short-term market. With a 4% 90-day spread ($36.09-$37.41), this card currently tracks as low-volatility.
Relative to the 30-day baseline ($37.11), pricing is near equilibrium. Top-grade copies show substantial separation from raw: PSA 10 is pricing +347% above the current raw benchmark.
PSA 9 is currently around $34.53, while PSA 10 is $167.20.
